Multiple sclerosis: Improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging

Radiology

Volumn 272, Issue 3, 2014, Pages 851-864

  Rudko, David A ^a,b   Solovey, Igor ^b   Gati, Joseph S ^b   Kremenchutzky, Marcelo ^c   Menon, Ravi S ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BIOLOGICAL MARKERS; BRAIN; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; NEURONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84906860730     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14132475     Document Type: Article

References (43)

1. Rudick RA, Lee JC, Nakamura K, Fisher E. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J Neurol Sci 2009;282(1-2):106-111.
2. Moraal B, Pohl C, Uitdehaag BM, et al. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Arch Neurol 2009;66(11):1345-1352.
3. LeVine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 1997;760(1-2):298-303.
4. Khalil M, Langkammer C, Ropele S, et al. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011;77(18):1691- 1697.
5. Khalil M, Enzinger C, Langkammer C, et al. Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler 2009;15(9):1048-1054.
6. Fernández-Seara MA, Wehrli FW. Postprocessing technique to correct for background gradients in image-based R*(2) measurements. Magn Reson Med 2000;44(3):358-366.
7. de Rochefort L, Liu T, Kressler B, et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med 2010;63(1):194-206.
8. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 2011;54(4):2789-2807.
9. Schweser F, Sommer K, Deistung A, Reichenbach JR. Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage 2012;62(3):2083-2100.
10. Deistung A, Schäfer A, Schweser F, Biedermann U, Turner R, Reichenbach JR. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength. Neuroimage 2013;65:299-314.
11. Wu B, Li W, Avram AV, Gho SM, Liu C. Fast and tissue-optimized mapping of magnetic susceptibility and T2* with multi-echo and multi-shot spirals. Neuroimage 2012;59(1):297-305.
12. Walsh AJ, Blevins G, Lebel RM, Seres P, Emery DJ, Wilman AH. Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. Radiology 2014;270(1):186-196.
13. Klassen LM, Menon RS. Robust automated shimming technique using arbitrary mapping acquisition parameters (RASTAMAP). Magn Reson Med 2004;51(5):881-887. (Pubitemid 38580598)
14. Curtis AT, Gilbert KM, Klassen LM, Gati JS, Menon RS. Slice-by-slice B1+ shimming at 7 T. Magn Reson Med 2012;68(4):1109-1116.
15. Peters AM, Brookes MJ, Hoogenraad FG, et al. T2* measurements in human brain at 1.5, 3 and 7 T. Magn Reson Imaging 2007;25(6):748-753.
16. Abdul-Rahman HS, Gdeisat MA, Burton DR, Lalor MJ, Lilley F, Moore CJ. Fast and robust three-dimensional best path phase unwrapping algorithm. Appl Opt 2007;46(26):6623-6635. (Pubitemid 350206715)
17. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. Neuroimage 2012;62(2):782-790.
18. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001;29(4):1165-1188. (Pubitemid 33575263)
19. Kitzler HH, Su J, Zeineh M, et al. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI. Neuroimage 2012;59(3):2670-2677.
20. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3(1):41-51.
21. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002;15(3):239-245. (Pubitemid 34596884)
22. Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M. Cell death and birth in multiple sclerosis brain. J Neurol Sci 1997;149(1):1-11. (Pubitemid 27196374)
23. Ge Y, Zohrabian VM, Osa EO, et al. Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J Magn Reson Imaging 2009;29(5):1190-1194.
24. Law M, Saindane AM, Ge Y, et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004;231(3):645-652. (Pubitemid 38668078)
25. Wuerfel J, Bellmann-Strobl J, Brunecker P, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004;127(pt 1):111-119. (Pubitemid 38055350)
26. Jochimsen TH, Ivanov D, Ott DV, et al. Whole-brain mapping of venous vessel size in humans using the hypercapnia-induced BOLD effect. Neuroimage 2010;51(2):765-774.
27. Kolind S, Matthews L, Johansen-Berg H, et al. Myelin water imaging reflects clinical variability in multiple sclerosis. Neuroimage 2012;60(1):263-270.
28. Aliotta R, Cox JL, Donohue K, et al. Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis. Hum Brain Mapp 2014;35(1):53-60.
29. Li TQ, van Gelderen P, Merkle H, Talagala L, Koretsky AP, Duyn J. Extensive heterogeneity in white matter intensity in high-resolution T2*-weighted MRI of the human brain at 7.0 T. Neuroimage 2006;32(3):1032-1040. (Pubitemid 44308284)
30. Laule C, Vavasour IM, Leung E, et al. Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology. Mult Scler 2011;17(2):144-150.
31. Langkammer C, Liu T, Khalil M, et al. Quantitative susceptibility mapping in multiple sclerosis. Radiology 2013;267(2):551-559.
32. Lebel RM, Eissa A, Seres P, Blevins G, Wilman AH. Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis. Mult Scler 2012;18(4):433-441.
33. Zivadinov R, Havrdová E, Bergsland N, et al. Thalamic atrophy is associated with development of clinically definite multiple sclerosis. Radiology 2013;268(3):831-841.
34. Love S. Demyelinating diseases. J Clin Pathol 2006;59(11):1151-1159. (Pubitemid 44787134)
35. Behbehani R. Clinical approach to optic neuropathies. Clin Ophthalmol 2007;1(3):233-246.
36. Trojano M, Liguori M, Bosco Zimatore G, et al. Age-related disability in multiple sclerosis. Ann Neurol 2002;51:475-480. (Pubitemid 34260777)
37. Trojano M, Avolio C, Manzari C, et al. Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry 1995;58:300-306.
38. Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS. Age dependence of clinical and pathological manifestations of autoimmune demyelination: implications for multiple sclerosis. Am J Pathol 1999;155:1147-1161. (Pubitemid 29488923)
39. Li W, Wu B, Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011;55(4):1645-1656.
40. Wheeler-Kingshott CA, Stroman PW, Schwab JM, et al. The current state-of-the-art of spinal cord imaging: applications. Neuroimage 2014;84:1082-1093.
41. Li W, Wu B, Avram AV, Liu C. Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings. Neuroimage 2012;59(3):2088-2097.
42. Lee J, Shmueli K, Kang BT, et al. The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain. Neuroimage 2012;59(4):3967-3975.
43. Bagnato F, Hametner S, Yao B, et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011;134(12):3602-3615.